FA2H, or Fatty Acid 2-Hydroxylase, is an enzyme involved in the metabolism of lipids, specifically in the hydroxylation of free fatty acids at the 2-position, leading to the production of 2-hydroxy fatty acids. These 2-hydroxy fatty acids play critical roles in the synthesis of specific classes of sphingolipids, which are essential components of the lipid bilayer in cell membranes. Sphingolipids containing 2-hydroxy fatty acids are particularly abundant in myelin, the insulating sheath that surrounds nerve fibers. By participating in the production of these particular sphingolipids, FA2H has a role in maintaining the proper structure and function of myelin. Therefore, the enzymatic action of FA2H is not only significant for lipid metabolism but also crucial for the proper functioning of the nervous system.
Inhibitors of FA2H are chemical entities designed to reduce or halt the enzymatic activity of FA2H. By interacting with the enzyme, these inhibitors can modulate the levels of 2-hydroxy fatty acids and, consequently, the synthesis of certain sphingolipids. The development and study of FA2H inhibitors provide valuable insights into the enzyme's role in lipid metabolism and cellular processes associated with it. Furthermore, these inhibitors can serve as molecular tools for researchers aiming to dissect the precise biochemical pathways in which FA2H is involved. The design of these inhibitors often stems from a detailed understanding of the FA2H enzyme's structure, its catalytic mechanism, and its interaction with substrates and cofactors. By studying the effects of these inhibitors on cells and tissues, researchers can further elucidate the broader roles of 2-hydroxy fatty acids and their derived sphingolipids in cellular physiology.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lipase Inhibitor, THL | 96829-58-2 | sc-203108 | 50 mg | $52.00 | 7 | |
Orlistat is a lipase inhibitor. Although its primary target is pancreatic lipase, it may indirectly influence lipid metabolic enzymes like FA2H. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
Simvastatin is an HMG-CoA reductase inhibitor affecting cholesterol synthesis. Changes in lipid metabolism might indirectly affect FA2H. | ||||||
Clofibrate | 637-07-0 | sc-200721 | 1 g | $33.00 | ||
As a PPARα agonist, it affects lipid metabolism. This modulation might indirectly influence FA2H expression. | ||||||
Gemfibrozil | 25812-30-0 | sc-204764 sc-204764A | 5 g 25 g | $66.00 $267.00 | 2 | |
Another PPARα agonist, it could indirectly impact FA2H by modifying lipid metabolic processes. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
By affecting lipid metabolism through PPARα activation, it might have indirect effects on FA2H. | ||||||
Lovastatin | 75330-75-5 | sc-200850 sc-200850A sc-200850B | 5 mg 25 mg 100 mg | $29.00 $90.00 $339.00 | 12 | |
A member of the statin class, it affects cholesterol synthesis and might indirectly impact FA2H. | ||||||
Probucol | 23288-49-5 | sc-203666 sc-203666A | 100 mg 1 g | $79.00 $166.00 | 5 | |
An antioxidant affecting lipid metabolism, it might influence FA2H indirectly. | ||||||
Nicotinic Acid | 59-67-6 | sc-205768 sc-205768A | 250 g 500 g | $62.00 $124.00 | 1 | |
Affects lipid profiles and might have an indirect role in FA2H modulation. | ||||||
Arachidonic Acid (20:4, n-6) | 506-32-1 | sc-200770 sc-200770A sc-200770B | 100 mg 1 g 25 g | $92.00 $240.00 $4328.00 | 9 | |
As a polyunsaturated fatty acid, it's involved in many lipid metabolic processes and might influence FA2H. | ||||||
Oleic Acid | 112-80-1 | sc-200797C sc-200797 sc-200797A sc-200797B | 1 g 10 g 100 g 250 g | $37.00 $104.00 $580.00 $1196.00 | 10 | |
A monounsaturated fatty acid that plays roles in lipid metabolism and might indirectly affect FA2H. | ||||||